Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$140,000 |
 |
ZomedicaZOM |
$4.1M |
 |
Johnson & JohnsonJNJ |
-$62M |
 |
Mind Medicine (MindMed)MNMD |
-$44M |
 |
ModernaMRNA |
-$256B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Buckbee Kevin K | Dec 16, 2024 | Sell | 1,800 | $172.24 | $310,000 |
| GONZALEZ RICHARD A | Aug 5, 2024 | Sell | 66,500 | $186.52 | $12M |
| GONZALEZ RICHARD A | Jul 17, 2024 | Sell | 282,845 | $175 | $49M |
| Donoghoe Nicholas | Mar 20, 2024 | Sell | 21,082 | $176.3 | $3.7M |
| Stewart Jeffrey Ryan | Mar 18, 2024 | Sell | 27,740 | $178.69 | $5M |
| Stewart Jeffrey Ryan | Mar 18, 2024 | Sell | 26,110 | $178.85 | $4.7M |
| Stewart Jeffrey Ryan | Mar 18, 2024 | Sell | 5,099 | $179.03 | $910,000 |
| RICHMOND TIMOTHY J. | Mar 1, 2024 | Sell | 30,288 | $177.71 | $5.4M |
| RICHMOND TIMOTHY J. | Mar 1, 2024 | Sell | 20,127 | $177.71 | $3.6M |
| RICHMOND TIMOTHY J. | Mar 1, 2024 | Sell | 15,412 | $176.4 | $2.7M |
| RICHMOND TIMOTHY J. | Mar 1, 2024 | Sell | 9,853 | $176.35 | $1.7M |
| Michael Robert A. | Feb 29, 2024 | Sell | 47,319 | $176.46 | $8.3M |
| Michael Robert A. | Feb 29, 2024 | Sell | 21,560 | $176.44 | $3.8M |
| Buckbee Kevin K | Feb 29, 2024 | Sell | 5,144 | $176.65 | $910,000 |
| Siatis Perry C | Feb 29, 2024 | Sell | 6,504 | $177.05 | $1.2M |
| Siatis Perry C | Feb 29, 2024 | Sell | 3,387 | $178.04 | $600,000 |
| GONZALEZ RICHARD A | Feb 28, 2024 | Sell | 138,616 | $177.27 | $25M |
| Reents Scott T | Feb 23, 2024 | Sell | 14,140 | $177.44 | $2.5M |
| Siatis Perry C | Feb 23, 2024 | Sell | 13,753 | $177.51 | $2.4M |
| SALEKI-GERHARDT AZITA | Feb 21, 2024 | Sell | 52,870 | $173.71 | $9.2M |
| Donoghoe Nicholas | Dec 26, 2023 | Sell | 2,912 | $154.72 | $450,000 |
| GONZALEZ RICHARD A | Aug 1, 2023 | Sell | 60,000 | $148.58 | $8.9M |
| GONZALEZ RICHARD A | Jul 31, 2023 | Sell | 18,500 | $149.15 | $2.8M |
| Sorg Elaine K. | Apr 25, 2023 | Sell | 6,130 | $165 | $1M |
| Sorg Elaine K. | Apr 17, 2023 | Sell | 6,999 | $161.64 | $1.1M |
| Sorg Elaine K. | Apr 17, 2023 | Sell | 500 | $162.04 | $81,000 |
| Sorg Elaine K. | Apr 3, 2023 | Sell | 15,002 | $160.03 | $2.4M |
| Siatis Perry C | Apr 3, 2023 | Sell | 3,520 | $160 | $560,000 |
| Stewart Jeffrey Ryan | Mar 13, 2023 | Sell | 31,315 | $152.27 | $4.8M |
| Stewart Jeffrey Ryan | Mar 13, 2023 | Sell | 21,810 | $152.3 | $3.3M |
| Sorg Elaine K. | Mar 1, 2023 | Sell | 15,003 | $155 | $2.3M |
| Siatis Perry C | Mar 1, 2023 | Sell | 11,330 | $153.06 | $1.7M |
| Reents Scott T | Mar 1, 2023 | Sell | 15,092 | $153.06 | $2.3M |
| SALEKI-GERHARDT AZITA | Mar 1, 2023 | Sell | 26,990 | $155 | $4.2M |
| RICHMOND TIMOTHY J. | Mar 1, 2023 | Sell | 27,395 | $153.0784 | $4.2M |
| RICHMOND TIMOTHY J. | Mar 1, 2023 | Sell | 16,746 | $153.62 | $2.6M |
| SALEKI-GERHARDT AZITA | Mar 1, 2023 | Sell | 9,220 | $153.05 | $1.4M |
| Siatis Perry C | Mar 1, 2023 | Sell | 805 | $153.38 | $120,000 |
| Reents Scott T | Mar 1, 2023 | Sell | 850 | $153.38 | $130,000 |
| SALEKI-GERHARDT AZITA | Mar 1, 2023 | Sell | 780 | $153.39 | $120,000 |
| Siatis Perry C | Feb 21, 2023 | Sell | 3,933 | $151.29 | $600,000 |
| Siatis Perry C | Feb 21, 2023 | Sell | 3,431 | $150.73 | $520,000 |
| Strom Carrie C | Feb 21, 2023 | Sell | 7,780 | $151.28 | $1.2M |
| Strom Carrie C | Feb 21, 2023 | Sell | 7,646 | $151.29 | $1.2M |
| Strom Carrie C | Feb 21, 2023 | Sell | 6,533 | $150.74 | $980,000 |
| Strom Carrie C | Feb 21, 2023 | Sell | 5,615 | $150.71 | $850,000 |
| Sorg Elaine K. | Feb 21, 2023 | Sell | 8,420 | $151.29 | $1.3M |
| Sorg Elaine K. | Feb 21, 2023 | Sell | 6,901 | $150.74 | $1M |
| Strom Carrie C | Feb 21, 2023 | Sell | 567 | $150.78 | $85,000 |
| Strom Carrie C | Feb 21, 2023 | Sell | 400 | $151.34 | $61,000 |
| AUSTIN ROXANNE S | Feb 17, 2023 | Sell | 10,000 | $150.5 | $1.5M |
| SALEKI-GERHARDT AZITA | Feb 17, 2023 | Sell | 14,246 | $149.13 | $2.1M |
| SALEKI-GERHARDT AZITA | Feb 17, 2023 | Sell | 10,754 | $150.05 | $1.6M |
What's the latest insider transaction for AbbVie?
The most recent insider transaction for AbbVie was conducted by Buckbee Kevin K, who sold 1,800 shares on December 16, 2024 at a price of $172.24 per share.
Which insider has sold the most ABBV stock over the last two years?
GONZALEZ RICHARD A has sold the most ABBV stock in the last 2 years, with a total value of $98M.
What is the total value of insider transactions for AbbVie (ABBV) in the last 2 years?
The total value of insider transactions for AbbVie in the last 2 years is negative, amounting to -$201M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on AbbVie's market confidence?
Over the last 2 years, insider transactions for AbbVie have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
